文献リスト

1) Kumru H, Stetkarova I, Schindler C, et al. Neurophysiological evidence for muscle tone reduction by intrathecal baclofen at the brain-stem level. Clin Neurophysiol. 2011; 122: 1229-37

2) Li DP, Pan HL. Role of GABAB receptors in autonomic control of systemic blood pressure. Adv Pharmacol. 2010; 58: 257-86

3) Albright AL, Ferson SS. Intraventricular baclofen for dystonia: techniques and outcomes. Clinical article. J Neurosurg Pediatr. 2009; 3: 11-4

4) Francisco GE, Yablon SA, Schiess MC, et al. Consensus panel guidelines for the use of intra-thecal baclofen therapy in poststroke spastic hyper-tonia. Top Stroke Rehabil. 2006; 13: 74-85

5) Kofler M, Quirbach E, Schauer R, et al. Limita-tions of intrathecal baclofen for spastic hemi-paresis following stroke. Neurorehabil Neural Repair. 2009; 23: 26-31

6) Schiess MC, Oh IJ, Stimming EF, et al. Prospective 12-month study of intratehcal baclofen therapy for poststroke spastic upper and lower extremity motor control and functional improvement. Neuromodulation. 2011; 14: 38-45

7) Taira T, Hori T. [Selective peripheral neurotomy and selective dorsal rhizotomy]. Brain Nerve ＝ Shinkei kenkyu no shinpo. 2008; 60: 1427-36

8) Sitthinamsuwan B, Chanvanitkulchai K, Nunta-Aree S, et al. Combined ablative neurosurgical procedures in a patient with mixed spastic and dystonic cerebral palsy. Stereotact Funct Neurosurg. 2010; 88: 187-92

9) Lynn AK, Turner M, Chambers HG. Surgical management of spasticity in persons with cer-ebral palsy. PM R. 2009; 1: 834-8

10) Tasseel Ponche S, Ferrapie AL, Chenet A, et al. Intrathecal baclofen in cerebral palsy. A retro-spective study of 25 wheelchair-assisted adults. Ann Phys Rehabil Med. 2010; 53: 483-98

11) Tilton A. Management of spasticity in children with cerebral palsy. Semin Pediatr Neurol. 2009; 16: 82-9

12) Ramstad K, Jahnsen R, Lofterod B, et al. Con-tinuous intrathecal baclofen therapy in children with cerebral palsy - when does improvement emerge？ Acta Paediatr. 2010; 99: 1661-5

13) Hoving MA, van Raak EP, Spincemaille GH, et al. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy. Eur J Paediatr Neurol. 2009; 13: 247-56

14) Krach LE. Intrathecal baclofen use in adults with cerebral palsy. Dev Med Child Neurol. 2009; 51 Suppl 4: 106-12

15) Burn SC, Zeller R, Drake JM. Do baclofen pumps influence the development of scoliosis in chil-dren？ J Neurosurg Pediatr. 2010; 5: 195-9

16) Krach LE, Kriel RL, Day SM, et al. Survival of individuals with cerebral palsy receiving continu-ous intrathecal baclofen treatment: a matched-cohort study. Dev Med Child Neurol. 2010; 52: 672-6

17) Raja SN. Motor dysfunction in CRPS and its treatment. Pain. 2009; 143: 3-4

18) Tran de QH, Duong S, Bertini P, et al. Treatment of complex regional pain syndrome: a review of the evidence. Can J Anaesth. 2010; 57: 149-66

19) van Rijn MA, Munts AG, Marinus J, et al. Intrathecal baclofen for dystonia of complex regional pain syndrome. Pain. 2009; 143: 41-7

20) van der Plas AA, Marinus J, Eldabe S, et al. The lack of efficacy of different infusion rates of intrathecal baclofen in complex regional pain syndrome: a randomized, double-blind, crossover study. Pain Med. 2011; 12: 459-65

21) Munts AG, van der Plas AA, Voormolen JH, et al. Intrathecal glycine for pain and dystonia in complex regional pain syndrome. Pain. 2009; 146: 199-204

22) Taira T. Intrathecal administration of GABA agonists in the vegetative state. Prog Brain Res. 2009; 177: 317-28

23) Sarà M, Pistoia F, Mura E, et al. Intrathecal baclofen in patients with persistent vegetative state: 2 hypotheses. Arch Phys Med Rehabil. 2009; 90: 1245-9

24) Oyama H, Kito A, Maki H, et al. Consciousness recovery induced by intrathecal baclofen admin-istration after subarachnoid hemorrhage -two case reports. Neurol Med Chir (Tokyo). 2010; 50: 386-90

25) Maramattom BV. Intrathecal baclofen pump implantation in a case of stiff person syndrome. Neurol India. 2010; 58: 115-7

26) Duddy ME, Baker MR. Stiff person syndrome. Front Neurol Neurosci. 2009; 26: 147-65

27) Erwin A, Gudesblatt M, Bethoux F, et al. Intra-thecal baclofen in multiple sclerosis: Too little, too late？ Mult Scler. 2011; 17: 623-9

28) Khan AA, Birks-Agnew I, Bullock P, et al. Clinical outcome and complications of intrathecal baclo-fen pump in multiple sclerosis patients: a retro-spective study. NeuroRehabilitation. 2010; 27: 117-20

29) DʼAleo G, Rifici C, Kofler M, et al. Seizure after intrathecal baclofen bolus in a multiple sclerosis patient treated with oxcarbazepine. Neurol Sci. 2011; 32: 293-5

30) Wait SD, Ponce FA, Killory BD, et al. Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article. J Neurosurg Pediatr. 2009; 4: 217-21

31) Kofler M, Poustka K, Saltuari L. Intrathecal baclofen for autonomic instability due to spinal cord injury. Auton Neurosci. 2009; 146: 106-10

32) 平 孝臣, 後藤真一, 佐々木寿之, 他. 【遺伝性痙性対麻痺 update】 痙性対麻痺のバクロフェン髄腔内投与療法. 神経内科. 2011; 74: 162-5

33) Santos ML, Mota-Miranda A, Alves-Pereira A, et al. Intrathecal baclofen for the treatment of tetanus. Clin Infect Dis. 2004; 38: 321-8

34) Engrand N, Van De Perre P, Vilain G, et al. Intrathecal baclofen for severe tetanus in a pregnant woman. Eur J Anaesthesiol. 2001; 18: 261-3

35) Saissy JM, Demaziere J, Vitris M, et al. Treat-ment of severe tetanus by intrathecal injections of baclofen without artificial ventilation. Intensive Care Med. 1992; 18: 241-4

36) Cabrerizo Garcia JL, Homs Gimeno CA, Pacheco Arancibia G, et al. [Treatment of tetanus with intrathecal baclofen]. An Med Interna. 2008; 25: 372-3

37) Solsona M, Miro G, Yebenes JC, et al. [Tetanus treated with continuous baclofen intrathecal perfusion]. Med Intensiva. 2007; 31: 204-6

38) Roberts AG, Graves CR, Konrad PE, et al. Intrathecal baclofen pump implantation during pregnancy. Neurology. 2003; 61: 1156-7

39) Muñoz FC, Marco DG, Pérez AV, et al. Pregnancy outcome in a woman exposed to continuous intrathecal baclofen infusion. Ann Pharmacother. 2000; 34: 956

40) Delhaas EM, Verhagen J. Pregnancy in a quadriplegic patient treated with continuous intrathecal baclofen infusion to manage her severe spasticity. Case report. Paraplegia. 1992; 30: 527-8

41) Morton CM, Rosenow J, Wong C, et al. Intra-thecal baclofen administration during pregnancy: a case series and focused clinical review. PM R. 2009; 1: 1025-9

42) DeVries-Rizzo M, Warren D, Delaney G, et al. Intrathecal baclofen and pregnancy: implications for clinical care. Can J Neurosci Nurs. 2009; 31: 21-4

43) Ali Sakr Esa W, Toma I, Tetzlaff JE, et al. Epidural analgesia in labor for a woman with an intrathecal baclofen pump. Int J Obstet Anesth. 2009; 18: 64-6

44) Albright AL. Intraventricular baclofen infusion for dystonia. Report of two cases. J Neurosurg. 2006; 105 (1 Suppl): 71-4

45) Turner MS. Assessing syndromes of catheter malfunction with SynchroMed infusion systems: the value of spiral computed tomography with contrast injection. PM R. 2010; 2: 757-66

46) Lind G, Schechtmann G, Winter J, et al. Baclofen-enhanced spinal cord stimulation and intrathecal baclofen alone for neuropathic pain: Long-term outcome of a pilot study. Eur J Pain. 2008; 12: 132-6

47) Schechtmann G, Lind G, Winter J, et al. Intra-thecal clonidine and baclofen enhance the pain-relieving effect of spinal cord stimulation: a com-parative placebo-controlled, randomized trial. Neurosurgery. 2010; 67: 173-81

48) 後藤真一, 平 孝臣, 堀 智勝. 複合型局所疼痛症候群I型の症状進行と脊髄電気刺激. 麻酔. 2009; 58: 1158-61

49) Teasell RW, Mehta S, Aubut JA, et al. A sys-tematic review of pharmacologic treatments of pain after spinal cord injury. Arch Phys Med Rehabil. 2010; 91: 816-31

50) Wallace MS, Rauck RL, Deer T. Ziconotide combination intrathecal therapy: rationale and evidence. The Clin J Pain. 2010; 26: 635-44

51) Saulino M. Simultaneous treatment of intractable pain and spasticity: observations of combined intrathecal baclofen-morphine therapy over a 10-year clinical experience. Eur J Phys Rehabil Med. 2011 Apr 28. [Epub ahead of print]

52) Sadiq SA, Poopatana CA. Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity. J Neurol. 2007; 254: 1464-5

53) Maugans TA. Intracranial migration of a frac-tured intrathecal catheter from a baclofen pump system: case report and analysis of possible causes. Neurosurgery. 2010; 66: 319-22

54) Nakaji P, Consiglieri GD, Garrett MP, et al. Cranial migration of a baclofen pump catheter associated with subarachnoid hemorrhage: case report. Neurosurgery. 2009; 65: E1212-3; discussion E3

55) 平 孝臣, 後藤真一, 赤川浩之, 他. 機器依存への警鐘 髄腔内バクロフェン投与ポンプ自体の故障について. 機能的脳神経外科. 2010; 49: 211-6

56) Ross JC, Cook AM, Stewart GL, et al. Acute intrathecal baclofen withdrawal: a brief review of treatment options. Neurocrit Care. 2011; 14: 103-8

57) Bellinger A, Siriwetchadarak R, Rosenquist R, et al. Prevention of intrathecal baclofen withdrawal syndrome: successful use of a temporary intra-thecal catheter. Reg Anesth Pain Med. 2009; 34: 600-2

58) Moberg-Wolff E. Potential clinical impact of compounded versus noncompounded intrathecal baclofen. Arch Phys Med Rehabil. 2009; 90: 1815-20

59) Stetkarova I, Yablon SA, Kofler M, et al. Pro-cedure- and device-related complications of intra-thecal baclofen administration for management of adult muscle hypertonia: a review. Neurorehabil Neural Repair. 2010; 24: 609-19

60) Sgouros S, Charalambides C, Matsota P, et al. Malfunction of SynchroMed II baclofen pump delivers a near-lethal baclofen overdose. Pediatr Neurosurg. 2010; 46: 62-5

61) Medtronic. Pump survival summary table. Medtronic; 2008; http://professional.medtronic.com/products/synchromed-II-spasticity/product-performance/index.htm]

62) Fjelstad AB, Hommelstad J, Sorteberg A. Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors. J Neurosurg Pediatr. 2009; 4: 487-93

63) Peerdeman SM, de Groot V, Feller RE. In situ treatment of an infected intrathecal baclofen pump implant with gentamicin-impregnated collagen fleece. J Neurosurg. 2010; 112: 1308-10

64) Heetla HW, Staal MJ, Kliphuis C, et al. The incidence and management of tolerance in intrathecal baclofen therapy. Spinal Cord. 2009; 47: 751-6

65) Dones I, Broggi G. A case of very long-term appearing drug tolerance to intrathecal baclofen. J Neurosurg Sci. 2010; 54: 77-8

66) Heetla HW, Staal MJ, van Laar T. Tolerance to continuous intrathecal baclofen infusion can be reversed by pulsatile bolus infusion. Spinal Cord. 2010; 48: 483-6

67) Medtronic. MRI Guidelines. 2009; http://professional.medtronic.com/products/synchromed-II-spasticity/mri-guidelines/index.htm]

68) Diehn FE, Wood CP, Watson RE Jr, et al. Clinical safety of magnetic resonance imaging in patients with implanted SynchroMed EL infusion pumps. Neuroradiology. 2011; 53: 117-22

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp